ExsoMed Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • ExsoMed's estimated annual revenue is currently $5.3M per year.(i)
  • ExsoMed's estimated revenue per employee is $251,000

Employee Data

  • ExsoMed has 21 Employees.(i)
  • ExsoMed grew their employee count by -19% last year.

ExsoMed's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
VP, Operations & Director OperationsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$20.3M817%N/AN/A
#2
$8.5M346%N/AN/A
#3
$4.5M18-10%N/AN/A
#4
$8M32-6%N/AN/A
#5
$5.3M210%N/AN/A
#6
$54.2M2169%N/AN/A
#7
$12M48N/AN/AN/A
#8
$10M405%N/AN/A
#9
$30.1M12022%N/AN/A
#10
$14.1M562%N/AN/A
Add Company

What Is ExsoMed?

Based in Aliso Viejo, CA, ExsoMed’s mission is to develop minimally-invasive, innovative solutions to enhance extremity implant procedures through increased surgical efficiency and improved patient outcomes.

keywords:N/A

N/A

Total Funding

21

Number of Employees

$5.3M

Revenue (est)

-19%

Employee Growth %

N/A

Valuation

N/A

Accelerator

ExsoMed News

2021-01-19 - ExsoMed Corporation Announces Nationwide Mobile Training and Cadaver Lab Program to Further Deliver Cutting-Edge Education and Training to Surgeons

ExsoMed's Mobile Training and Cadaver Lab "ExsoMed is committed to surgeon education and training," said James Young Kim, ExsoMed's Managing Director of Global Sales & Mktg. "So we have decided to bring the training to surgeons, making it convenient and safe to continue experiencing the latest i ...

2020-08-31 - ExsoMed Completes Second Financing Round

ExsoMed Corporation, an Aliso Viejo, Calif.-based medical device company providing orthopaedic surgeons with innovative solutions in hand surgery, completed its second round of financing of undisclosed amount. This round, comprised entirely of private investors, included participation from both ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$5.3M210%N/A
#2
$2.4M23N/AN/A
#3
$2.3M235%N/A
#4
$2.3M230%N/A
#5
$2.3M23-4%N/A